Search

Your search keyword '"Obesity -- Care and treatment"' showing total 3,942 results
Start Over Descriptor "Obesity -- Care and treatment"
3,942 results on '"Obesity -- Care and treatment"'

1. Combined hormonal contraceptives merit risk assessment in patients with obesity: Combined hormonal contraceptives such as the combined oral contraceptive pill, the patch, and the vaginal ring each have unique considerations for use in patients with obesity

Author

Rankin, Holly A. and Zwerling, Blake

Subjects
Obesity -- Care and treatment, Risk assessment -- Reports, Transdermal medication -- Reports, Estrogen -- Reports, Health, Twirla (Contraceptive) -- Reports
Abstract

In the United States, obesity now affects 40% of reproductive-aged women. (1) Despite lower fecundity of pregnancy-capable people with obesity, the possibility of an unplanned pregnancy remains. (2) Therefore, an [...]

Published
2024

2. Investigators from University of California San Francisco (UCSF) Zero in on Obesity, Fitness and Wellness (Transforming Health Care From Volume To Value : Targeting Essential Therapies for Improved Health)

Subjects
Obesity -- Care and treatment, Physical fitness -- Health aspects, Health, University of California
Abstract

2024 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Obesity, Fitness and Wellness have been published. According [...]

Published
2024

3. Investigators from Dokkyo Medical University Have Reported New Data on Obesity, Fitness and Wellness (A Cml Patient Carrying Bcr::abl1 Splicing Variants Did Not Experience Blast Crisis for 15 Years Without Responding To Various Tkis)

Subjects
Obesity -- Care and treatment, Nilotinib -- Health aspects, Physical fitness -- Health aspects, Health
Abstract

2024 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Obesity, Fitness and Wellness have been published. According [...]

Published
2024

4. New Findings on Obesity Described by Investigators at Azienda Ospedaliero Universitaria di Modena (Weight Loss As Therapeutic Option To Restore Fertility In Obese Men: a Meta-analytic Study)

Subjects
Care and treatment, Analysis, Health aspects, Obesity -- Care and treatment, Physical fitness -- Analysis -- Health aspects, Body weight -- Health aspects -- Analysis, Medical research -- Analysis -- Health aspects, Weight loss -- Care and treatment, Medicine, Experimental -- Analysis -- Health aspects
Abstract

2024 OCT 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Nutritional and Metabolic Diseases and Conditions - Obesity [...]

Published
2024

5. Data from Department of Urology Provide New Insights into Obesity, Fitness and Wellness (Retreatment for Lower Urinary Tract Symptoms After Water Vapor Thermal Therapy)

Subjects
Boston Scientific Corp., Obesity -- Care and treatment, Medical test kit industry -- Health aspects, Medical equipment and supplies industry -- Health aspects, Physical fitness -- Health aspects, Health
Abstract

2024 SEP 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Obesity, Fitness and Wellness are presented in a new [...]

Published
2024

6. Study Findings on Cancer Described by a Researcher at University of Edinburgh (522. Multi-slice, Volumetric Computed Tomography Body Composition Analysis in Patients With Oesophagogastric Cancer)

Subjects
Oncology, Experimental -- Reports, Obesity -- Care and treatment, Cancer -- Care and treatment -- Research, CT imaging -- Reports, Physical fitness -- Reports, Health, University of Edinburgh -- Reports
Abstract

2024 SEP 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on cancer. According to news reporting originating from [...]

Published
2024

7. Scholar Rock: Enrollment complete in Phase 2 trial of apitegromab for obesity

Subjects
Obesity -- Care and treatment, Clinical trials, Company business planning, Business, News, opinion and commentary
Abstract

Scholar Rock announced it has completed enrollment in the Phase 2 EMBRAZE trial designed to show proof-of-concept of apitegromab, an investigational selective myostatin inhibitor antibody, to safely preserve lean muscle [...]

Published
2024

8. Patients are struggling to fill obesity drug prescriptions

Subjects
Obesity -- Care and treatment, Hypoglycemic agents -- Supply and demand, Type 2 diabetes -- Care and treatment, Pharmaceutical industry -- Logistics
Abstract

To listen to this broadcast, click here: http://www.npr.org/templates/transcript/transcript.php?storyId=nx-s1-5066786 BYLINE: SYDNEY LUPKIN HOST: ARI SHAPIRO ARI SHAPIRO: The pharmaceutical companies behind blockbuster weight loss and diabetes drugs have signaled that their […]

Published
2024

9. Palatin doses first patient in Phase 2 study of bremelanotide in obesity

Subjects
Medical research, Medicine, Experimental, Obesity -- Care and treatment, Intermedin, Clinical trials, Business, News, opinion and commentary
Abstract

Palatin announced that patient dosing has started for the clinical study designed to enroll up to 60 patients at four trial sites in the United States with the primary endpoint [...]

Published
2024

10. Factors that influence general practitioners' obesity-related clinical practices and determinants of behaviour to target to promote best practice in obesity care: a qualitative exploration (Updated July 30, 2024)

Subjects
Obesity -- Care and treatment, Medicine -- Practice, Family medicine, Physical fitness, Physicians (General practice), Health
Abstract

2024 AUG 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2024

11. Veru reaches full enrollment for phase 2b QUALITY study of enobosarm for obesity

Subjects
Obesity -- Care and treatment, Clinical trials, Weight loss -- Care and treatment, Pharmaceuticals and cosmetics industries
Abstract

Veru Inc., a late clinical stage biopharmaceutical company, provided a business update including progress on its phase 2b QUALITY clinical trial and announced financial results for its fiscal 2024 third [...]

Published
2024

12. Investigators at Bar Ilan University Describe Findings in Obesity, Fitness and Wellness (Apps Don ' T Work for Patients Who Don ' T Use Them: Towards Frameworks for Digital Therapeutics Adherence)

Subjects
Obesity -- Care and treatment, Patient compliance, Physical fitness, Health, Bar-Ilan University
Abstract

2024 AUG 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Obesity, Fitness and Wellness have been published. According [...]

Published
2024

13. Wedbush starts Corbus with Outperform on cancer and obesity potential

Subjects
Obesity -- Care and treatment, Cancer -- Care and treatment, Business, News, opinion and commentary
Abstract

Wedbush last night initiated coverage of Corbus Pharmaceuticals with an Outperform rating and $85 price target. Corbus is an early clinical stage biotech developing therapies for cancer and obesity, the [...]

Published
2024

15. Reports from University Hospital of Liege Describe Recent Advances in Obesity (Gestational Weight Gain: Toward Best Practices In Managing Gestational Weight Gain In Patients With Obesity: Comparison of Recommendations)

Subjects
Obesity -- Care and treatment, Body mass index -- Reports -- Comparative analysis, Weight loss -- Care and treatment, Physical fitness -- Comparative analysis -- Reports, Health
Abstract

2024 JUL 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Nutritional and Metabolic Diseases and Conditions - [...]

Published
2024

18. Investigators at University of Missouri Report Findings in Obesity (A Systematic Review and Meta-analysis Combing Adolescent and Adult Data To Evaluate Weight Loss and the Effect of Age Following the Laparoscopic Sleeve Gastrectomy)

Subjects
Laparoscopy, Obesity -- Care and treatment, Laparoscopic surgery, Weight loss -- Care and treatment, Physical fitness, Health
Abstract

2024 JUN 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Nutritional and Metabolic Diseases and Conditions - Obesity [...]

Published
2024

19. Break the Binge Eating Cycle

Author

Blum, Dani

Subjects
Obesity -- Care and treatment, Behavior therapy -- Methods, Compulsive eating -- Care and treatment, Weight reducing preparations -- Health aspects, General interest, News, opinion and commentary
Abstract

Doctors are already using weight loss drugs to treat binge eating disorder. But some experts warn that it's a Band-Aid, not a fix. People taking drugs like Ozempic say their [...]

Published
2024

21. Are Obesity Drugs A Lifelong Treatment?

Author

Kolata, Gina

Subjects
Obesity -- Care and treatment, Body weight -- Analysis, Weight reducing preparations -- Analysis, Weight loss -- Drug therapy -- Methods, General interest, News, opinion and commentary
Abstract

Many patients are eager to discontinue Wegovy or Zepbound when their weight loss plateaus. But doctors say it's difficult to go cold turkey. Susana Parks was delighted when she lost [...]

Published
2024

22. Baseline Characteristics of PATHWEIGH: A Stepped-Wedge Cluster Randomized Study for Weight Management in Primary Care

Author

Perreault, Leigh, Suresh, Krithika, Rodriguez, Carlos, Dickinson, L. Miriam, Willems, Emileigh, Smith, Peter C., Williams, Johnny, Jr., Gritz, R. Mark, and Holtrop, Jodi Summers

Subjects
Obesity -- Care and treatment, Primary health care -- Methods, Weight loss -- Methods, Health, Science and technology
Abstract

PURPOSE To describe the characteristics of patients and practice of clinicians during standard-of-care for weight management in a large, multiclinic health system before the implementation of PATHWEIGH, a pragmatic weight management intervention. METHODS We analyzed baseline characteristics of patients, clinicians, and clinics during standard-of-care for weight management before the implementation of PATHWEIGH, which will be evaluated for effectiveness and implementation in primary care using an effectiveness-implementation hybrid type-1 cluster randomized stepped-wedge clinical trial design. A total of 57 primary care clinics were enrolled and randomized to 3 sequences. Patients included in the analysis met the eligibility requirements of age [greater than or equal to] 18 years and body mass index (BMI) [greater than or equal to] 25 kg/[m.sup.2] and had a weight-prioritized visit (defined a priori) during the period March 17, 2020 to March 16, 2021. RESULTS A total of 12% of patients aged [greater than or equal to] 18 years and with a BMI [greater than or equal to] 25 kg/[m.sup.2] seen in the 57 practices during the baseline period (n = 20,383) had a weight-prioritized visit. The 3 randomization sequences of 20, 18, and 19 sites were similar, with an overall mean patient age of 52 (SD 16) years, 58% women, 76% non-Hispanic White patients, 64% with commercial insurance, and with a mean BMI of 37 (SD 7) kg/[m.sup.2]. Documented referral for anything weight related was low ( CONCLUSIONS Of patients aged [greater than or equal to] 18 years and with a BMI [greater than or equal to] 25 kg/[m.sup.2] in a large health system, 12% had a weight-prioritized visit during the baseline period. Despite most patients being commercially insured, referral to any weight-related service or prescription of antiobesity drug was uncommon. These results fortify the rationale for trying to improve weight management in primary care. Key words: body mass index; primary care; weight management https://doi.org/10.1370/afm.2966, INTRODUCTION Obesity remains one of the greatest current public health challenges, contributing to 4,000,000 deaths and 120,000,000 disability-adjusted life-years globally in 2015. (1) Despite the human and economic costs of [...]

Published
2023
Full Text
View/download PDF

23. Investigators at National Polytechnic Institute Discuss Findings in Female Infertility (Obesity Attenuates the Beneficial Effect of an Intrauterine Infusion of Autologous Platelet-rich Plasma During In Vitro Fertilization)

Subjects
Women -- Health aspects, Medical research -- Reports, Medicine, Experimental -- Reports, Obesity -- Care and treatment, Fertilization in vitro -- Reports, Technical institutes -- Reports, Infertility, Female -- Care and treatment, Health, Women's issues/gender studies
Abstract

2024 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Research findings on Reproductive Medicine - Female Infertility are discussed in a new report. [...]

Published
2024

24. Researchers from University of Maryland Detail Findings in Obesity (The Effect of Broccoli Glucoraphanin Supplementation On Ameliorating High-fat-diet-induced Obesity Through the Gut Microbiome and Metabolome Interface)

Subjects
Broccoli -- Chemical properties -- Health aspects, Obesity -- Care and treatment, Microbiota (Symbiotic organisms) -- Physiological aspects -- Health aspects, Metabolites -- Physiological aspects -- Health aspects, Health
Abstract

2024 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Nutritional and Metabolic Diseases and Conditions - Obesity [...]

Published
2024

25. Data on Obesity Reported by Researchers at University of California San Diego (UCSD) (Adipose Tissue Macrophages Secrete Small Extracellular Vesicles That Mediate Rosiglitazone-induced Insulin Sensitization)

Subjects
Obesity -- Care and treatment, Adipose tissues -- Physiological aspects -- Health aspects, Insulin resistance -- Risk factors, Macrophages -- Physiological aspects -- Health aspects, Thiazolidinediones -- Dosage and administration -- Complications and side effects
Abstract

2024 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Nutritional and Metabolic Diseases and Conditions - [...]

Published
2024

26. Universidad Internacional Researcher Has Published New Data on Obesity (Incidence of a Multicomponent Physical Exercise Program on Body Composition in Overweight or Obese People Aged 60 Years or Older from Chile)

Subjects
Aged -- Physiological aspects -- Health aspects -- Care and treatment, Obesity -- Care and treatment, Body composition -- Health aspects, Exercise therapy -- Methods, Exercise therapy for the aged -- Methods
Abstract

2024 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in obesity. According to news reporting out of [...]

Published
2024

27. New Obesity, Fitness and Wellness Findings Reported from Indian Institute of Technology (IIT) Kanpur ['synthesis, Characterization and Application of Xanthated diospyros Kaki (Persimmon) Leaves for the Treatment of Chemical and Bi

Subjects
Obesity -- Care and treatment, Physical fitness -- Health aspects, Health
Abstract

2024 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Obesity, Fitness and Wellness have been published. According [...]

Published
2024

28. Researchers from Hebei Medical University Report Findings in Insulin Resistance (Clinical Observation of Laparoscopic Sleeve Gastrectomy and Metformin Treatment In Obese Pcos Patients)

Subjects
Laparoscopy -- Methods, Obesity -- Care and treatment, Laparoscopic surgery -- Methods, Metformin -- Dosage and administration, Stein-Leventhal syndrome -- Care and treatment, Gastrectomy -- Methods, Health
Abstract

2024 MAY 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Endocrine System Diseases and Conditions - Insulin Resistance have [...]

Published
2024

31. Data from Texas Health Presbyterian Hospital Dallas Provide New Insights into Obesity (Ventilatory Limitations In Patients With Hfpef and Obesity)

Subjects
United States. National Institutes of Health, Medical research, Medicine, Experimental, Obesity -- Care and treatment, Physical fitness, Health, Texas Health Presbyterian Hospital
Abstract

2024 MAR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Nutritional and Metabolic Diseases and Conditions - Obesity [...]

Published
2024

32. Cytoki Pharma Announces First Patient Dosed in Phase 2 Study of CK-0045 in Obesity and Type 2 Diabetes

Subjects
Medical research, Medicine, Experimental, Obesity -- Care and treatment, Type 2 diabetes -- Care and treatment, General interest, News, opinion and commentary
Abstract

COPENHAGEN: Cytoki Pharma has issued the following press release: Cytoki Pharma, ApS (Cytoki), a clinical-stage biotechnology company pioneering a new class of medicines that harness IL-22 biology to drive improved [...]

Published
2024

33. Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek 2024

Subjects
Obesity -- Care and treatment, Type 2 diabetes -- Care and treatment, Weight loss -- Care and treatment, Business, News, opinion and commentary
Abstract

Up to 6.8% Placebo-Adjusted Mean Weight Loss (8.2% from Baseline) After 28 Days of Dosing with Oral Tablet of VK2735 Encouraging Tolerability Through 100 mg Daily Dosing with Oral VK2735; [...]

Published
2024

34. Palatin Completes Enrollment in Phase 2 Clinical Study of Bremelanotide (MC4R Agonist) Co-Administered with Tirzepatide (GLP-1/GIP) for the Treatment of Obesity

Subjects
Biological products industry -- Product development, Obesity -- Care and treatment, Body weight, Intermedin, Clinical trials, Weight loss -- Care and treatment, Palatin Technologies Inc. -- Product development
Abstract

Topline results expected in 1Q calendar year 2025 Study is assessing the co-administration of bremelanotide and tirzepatide on reducing body weight Data will inform and support the Company's obesity programs [...]

Published
2024

36. CMU-LED PROJECT TO FIGHT OBESITY, TYPE 2 DIABETES RECEIVES ARPA-H BACKING

Subjects
United States. Defense Advanced Research Projects Agency, Light-emitting diodes, Obesity -- Care and treatment, Diabetes therapy, Type 2 diabetes -- Care and treatment, News, opinion and commentary, Carnegie Mellon University
Abstract

PITTSBURGH, PA -- The following information was released by Carnegie Mellon University: By: Sara Pecchia Email A Carnegie Mellon University-led team of researchers has secured an award of up to [...]

Published
2024

37. Rice's Biotech Launch Pad to lead commercialization of bioelectrical implant treatment for obesity, type 2 diabetes

Subjects
Food -- Biotechnology, Obesity -- Care and treatment, Diabetes therapy, Patient compliance, Biotechnology, Type 2 diabetes -- Care and treatment, Genetically engineered foods, Business, News, opinion and commentary, Rice University
Abstract

$34.9M ARPA-H project aims to disrupt therapies' market and radically improve treatment options HOUSTON, Oct. 2, 2024 /PRNewswire/ -- Rice University is part of a multiuniversity research team that has [...]

Published
2024

39. Rivus Pharmaceuticals Announces New Clinical Data from Phase 2a HuMAIN Trial Demonstrating Significant Weight Loss with HU6 in Patients with Obesity-Related Heart Failure

Subjects
Care and treatment, Product development, Heart failure -- Care and treatment, Obesity -- Care and treatment, Weight loss -- Care and treatment
Abstract

CHARLOTTESVILLE: Rivus Pharmaceuticals has issued the following news release: Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to improving metabolic health, today announced new clinical data from the Phase 2a [...]

Published
2024

40. Rivus Pharmaceuticals Announces New Clinical Data from Phase 2a HuMAIN Trial Demonstrating Significant Weight Loss with HU6 in Patients with Obesity-Related Heart Failure

Subjects
Obesity -- Care and treatment, Weight loss -- Care and treatment, Heart failure -- Care and treatment
Abstract

-- Results from the placebo-controlled study in patients with obesity-related heart failure with preserved ejection fraction (HFpEF) were presented in a Late Breaking Clinical Trial Plenary Session at the HFSA [...]

Published
2024

41. NEW CDC DATA SHOW ADULT OBESITY PREVALENCE REMAINS HIGH

Subjects
United States. Centers for Disease Control and Prevention -- Officials and employees, Exercise, Obesity -- Care and treatment, Adults, Type 2 diabetes -- Care and treatment, Physical fitness
Abstract

ATLANTA, GA -- The following information was released by the Centers for Disease Control and Prevention (CDC): New CDC population data from 2023 show that in 23 states more than […]

Published
2024

42. Obesity Drug May Prevent Covid Deaths, Study Suggests

Author

Kolata, Gina

Subjects
Obesity -- Care and treatment, Weight reducing preparations -- Health aspects, General interest, News, opinion and commentary
Abstract

Many patients are eager to discontinue Wegovy or Zepbound when their weight loss plateaus. But doctors say it's difficult to go cold turkey. Susana Parks was delighted when she lost [...]

Published
2024

44. Could your cat really help unlock the secrets to obesity?

Subjects
Obesity -- Care and treatment, Microbiota (Symbiotic organisms), Cats, Business, General interest, Business, international, News, opinion and commentary, The Ohio State University
Abstract

PARIS, July 23 -- In recent years, the scientific community has become increasingly interested in the intestinal microbiota. This is because the microorganisms living in our digestive tract are endowed [...]

Published
2024

47. Effect of high-intensity interval training and high-intensity resistance training on irisin and fibroblast growth factor 21 in men with overweight and obesity

Author

Haghighi, Amir Hossein, Hajinia, Morteza, Askari, Roya, Abbasian, Sadegh, and Goldfied, Gary

Subjects
Peptide hormones -- Health aspects, Obesity -- Care and treatment, Fibroblast growth factors -- Health aspects, Biological sciences
Abstract

Adipose tissue browning is a physiological process that increases energy expenditure and may combat against obesity and its related risk factors. Fibroblast growth factor 21 (FGF21) and irisin, hormones affected by exercise that also affect adipose tissue browning, have not been widely studied with regard to exercise type and duration. This study compared the effect of high-intensity interval training (HIIT) and high-intensity resistance training (HIRT) on irisin and FGF21 in men living with overweight and obesity. After completing a training program three times weekly for 8 weeks, participants' serum levels of irisin and FGF21 were significantly increased in the HIIT and HIRT groups compared with the control group (p < 0.05). Additionally, body fat percentage and body weight in both training groups were significantly reduced in comparison with the control group (p < 0.05). Thus, HIIT and HIRT programs may be used as a feasible modality to promote favourable changes in body composition and irisin and FGF21, factors critical for browning white adipose tissue in men living with overweight and obesity. Key words: adipose tissue, fibroblast growth factor 21, interval training, irisin, obesity, resistance training Le brunissement du tissu adipeux est un processus physiologique, qui entraine une augmentation des depenses energetiques et qui pourrait permettre de contrer l'obesite et les facteurs de risque qui y sont lies. Le facteur de croissance des fibroblastes 21 (ou FGF21 pour << fibroblast growth factor 21 >>) et l'irisine, des hormones touchees par l'exercice physique qui modifient aussi le brunissement du tissu adipeux, n'ont pas ete largement etudies quant au type d'exercice physique et a sa duree. Cette etude consistait a comparer l'effet de l'entrainement fractionne de haute intensite (ou HIIT pour << high-intensity interval training >>) et de l'entrainement contre resistance de haute intensite (ou HIRT pour << high-intensity resistance training >>) sur l'irisine et le FGF21 chez des hommes aux prises avec un surpoids et de l'obesite. Apres avoir termine un programme d'entrainement physique trois fois par semaine pendant huit semaines, on observait chez les participants une augmentation nettement plus marquee des taux seriques d'irisine et de FGF21 dans les groupes HIIT et HIRT que chez les temoins (p < 0,05). De plus, le pourcentage de tissu adipeux corporel et la masse corporelle diminuaient nettement plus dans les deux groupes d'entrainement que chez les temoins (p < 0,05). Par consequent, les programmes de HIIT et de HIRT pourraient etre utilises comme modalite realisable en vue de favoriser des modifications favorables quant a la composition de l'organisme, de meme qu'en matiere d'irisine avec de FGF21, des facteurs cruciaux pour le brunissement du tissu adipeux blanc chez les hommes aux prises avec un surpoids et de l'obesite. [Traduit par la Redaction] Mots-cles : tissu adipeux, facteur de croissance des fibroblastes 21, entrainement fractionne, irisine, obesite, entrainement contre resistance, Introduction Obesity as a multifactorial disease has adverse effects on health and economic outcomes (Bray et al. 2018). Previous studies have reported that increased adipose tissue mass as the main [...]

Published
2022
Full Text
View/download PDF

48. Weight Management Treatments Increase Weight Loss in Patients With Obesity

Subjects
Obesity -- Care and treatment, Weight loss -- Care and treatment, Health
Abstract

HealthDay News — For patients with obesity, weight management treatments (WMTs) are associated with an increased probability of 5% or greater weight loss, according to a study published online in [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results